The rapid rise of glucagon-like peptide-1 (GLP-1) receptor agonists has fundamentally transformed the landscape of metabolic medicine, offering unprecedented efficacy…
Read More
UC San Francisco Researchers Identify FTL1 Protein as Key Driver of Hippocampal Aging and Memory Loss in New Study
The aging process has long been recognized as the primary risk factor for a wide array of neurodegenerative conditions, with…
Read More
Internalized Stress and Feelings of Hopelessness Linked to Accelerated Memory Loss Among Older Chinese Americans According to Rutgers Study
New research from the Rutgers Institute for Health, Health Care Policy and Aging Research has identified a significant correlation between…
Read More
Lilly’s triple agonist achieves 16.8% weight loss in phase 3 trial
Eli Lilly and Company today announced groundbreaking results from a Phase 3 clinical trial for its investigational triple agonist, retatrutide,…
Read More
Brain Immune System Response Linked to Early Loss of Smell in Alzheimer’s Disease Patients
The decline of the olfactory sense has long been observed as a precursor to the cognitive deterioration associated with Alzheimer’s…
Read More
Eli Lilly Soars Past Expectations on Unabated Weight-Loss Drug Demand, Raises Full-Year Forecast
Eli Lilly and Company has once again demonstrated its formidable market power, reporting first-quarter 2026 sales that significantly surpassed analyst…
Read More
Eliquis Loss of Exclusivity: A Pharmaceutical Patent Cliff of Historic Proportions
The pharmaceutical industry is bracing for one of the most significant patent cliff events in its history as Eliquis, the…
Read More
Salk Institute Researchers Identify BCL6 Protein as Key to Preventing Muscle Loss During GLP-1 Weight Management and Aging
The pharmaceutical landscape of the 21st century has been fundamentally altered by the advent of glucagon-like peptide-1 (GLP-1) receptor agonists.…
Read More
Internalized Stress Linked to Heightened Risk of Memory Loss in Older Chinese Americans According to Rutgers Study
New research from Rutgers Health suggests that the psychological tendency to turn stress inward—a phenomenon often characterized by feelings of…
Read More
Eli Lilly’s Triple Agonist Achieves 16.8% Weight Loss in Phase 3 Trial
Eli Lilly and Company today announced groundbreaking results from a Phase 3 clinical trial for its investigational triple agonist, retatrutide,…
Read MoreYOU MAY HAVE MISSED
